Menu
Enrolling by invitation NCT05879211

Goal Concordant Care Learning Laboratory

No phase Interventional Cancer Heart Failure Copd Dementia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Feedback.
Who it may be relevant to
Registry conditions: Cancer, Heart Failure, Copd, Dementia. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Palliative Care Learning Laboratory

Overview

The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness.

Detailed description

The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness. The lab will test a variety of interventions, including triggered conversations and feedback to healthcare providers.

Interventions

  • Behavioral Feedback
    Providers will receive detailed feedback about the timing, quality, and frequency of their goals of care communication with patients

Primary outcome measures

  • Frequency of goals of care communication [Time frame: 2 years]
  • Timing of goals of care communication [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Duke Health patient

Exclusion criteria

  • None

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Duke Health — Durham

Identifiers

NCT: NCT05879211 · Pro00106230

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗